Table 1 Characteristics of the study population to estimate the prevalence of Alzheimer’s disease (AD)
From: Is it time to use real-world data from primary care in Alzheimer’s disease?
Characteristics | Study population (N = 1,048,956) | Identified patients with AD (N = 39,448) | Other patients (N = 1,009,508) |
|---|---|---|---|
Age, x̅(sd) | 75.9 (7.9) | 83.1 (6.6) | 75.6 (7.8) |
Women, n (%) | 599,942 (57.2) | 28,360 (71.9) | 571,582 (56.6) |
Rurality, n (%) | 192,764 (19.1) | 8021 (20.3) | 200,785 (19.1) |
Anemia, n (%) | 160,524 (15.3) | 9852 (25.0) | 150,672 (14.9) |
Cerebrovascular disease, n (%) | 107,475 (10.3) | 6659 (16.9) | 100,816 (10.0) |
Coronary heart disease, n (%) | 100,871 (9.6) | 3995 (10.1) | 96,876 (9.6) |
Diabetes mellitus, n (%) | 258,214 (24.6) | 10,732 (27.2) | 247,482 (24.5) |
Hyperlipidemia, n (%) | 567,751 (54.1) | 22,144 (56.1) | 545,607 (54.1) |
Hypertension, n (%) | 673,663 (64.2) | 27,490 (69.7) | 646,173 (64.0) |
Depression, n (%) | 175,765 (16.8) | 11,222 (28.5) | 164,543 (16.3) |